Alveolar bone loss, platelet and glycosylated haemoglobin levels in 239 patients. A clinical study by Pérez-Sayáns, Mario et al.
e318
Med Oral Patol Oral Cir Bucal. 2020 May 1;25 (3):e318-25. Platelet and HBA1c levels and alveolar bone loss
Journal section: Medically compromised patients in Dentistry
Publication Types: Research
Alveolar bone loss, platelet and glycosylated haemoglobin levels 
in 239 patients. A clinical study
Mario Pérez-Sayáns 1,2, Andrés Blanco-Carrión 1,2, Abel García-García 2,3, Cintia M Chamorro-Petronacci 1,2, 
Karem L Ortega 4, Juan Suárez-Quintanilla 5
1 DDS, PhD. Oral Medicine, Oral Surgery and Implantology Unit. Faculty of Medicine and Dentistry, Santiago de Compostela University
2 Instituto de Investigación Sanitaria de Santiago (Sanitary Research Institute of Santiago) (IDIS), Santiago de Compostela, Spain
3 MD, PhD. Oral Medicine, Oral Surgery and Implantology Unit. Faculty of Medicine and Dentistry, Santiago de Compostela University
4 DDS, MDS, PhD. Oral and Maxillofacial Pathology, School of Dentistry, University of São Paulo, São Paulo, Brazil
5 PhD, MD. Anatomy Department, Santiago de Compostela University. Primary care dentist SERGAS (Galician Health Service)
Correspondence:
Oral Medicine, Oral Surgery and Implantology Unit
Faculty of Medicine and Dentistry
Santiago de Compostela University





Background: The relation between periodontal disease and systemic pathologies is still not widespread among general 
practitioners. The aim of our study is to evaluate whether or not periodontal radiological diagnosis can aid the detection 
of blood alterations associated with acquired systemic diseases.
Material and Methods: This is a cross sectional study. All of the participants underwent a panoramic radiograph and a 
complete blood test. Morphological bone loss was considered as positive in those patients who showed radiographically 
more than 1 tooth with bone loss greater than or equal to the middle third of the root. The statistical analysis was per-
formed by comparing the variables using the ANOVA or U-Mann-Whitney tests for independent samples with normal 
conditions. The correlation coefficient was analysed using the Pearson test.
Results: 239 patients were included in our study (96 men and 143 women) with an average age of 64.40 years. 59.04% of 
the patients were determined as morphological bone loss positive and had on average 4 teeth less than negative patients 
(p <0.0001). Also the average platelet levels in positive patients were lower (p = 0.024) and mean levels of HBA1c (p = 
0.009) were higher.
Conclusions: Morphological bone loss parameter can be useful both for dentists and general practitioners to refer, sub-
sequently, to periodontal specialist.
Key words: Periodontal diseases, blood chemical analysis, blood platelets, alkaline phosphatase, glycosylated hae-
moglobin A, alveolar bone loss.
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Introduction
Periodontal disease (PD) is a chronic inflammatory 
process that damages the tissues surrounding the teeth, 
causing the progressive loss of the alveolar bone, which, 
in very advanced or very aggressive cases induces the 
loss of teeth, and, from an anatomical point of view 
causes the destruction of the ligament of the alveolo-
dental gomphosis (1). PD, and dental caries are the most 
commonly diagnosed and treated pathologies in dental 
consultations, but from a medical point of view, PD is 
considered to be a chronic inflammatory disease (2). 
That is to say that it is categorised as a disease in which 
the body’s defence system alters the cellular DNA 
mechanisms due to excessive inflammation time, given 
that these are designed to repair tissues with short-term 
anti-inflammatory mechanisms.
For this reason, the manner in which chronic PD is eval-
uated differs in dental and medical practice. In dental 
practice the disease must be measured in order to as-
sess its evolution in each tooth by implementing tech-
niques which require a complex instruction such as the 
periodontal pocket probing depth, the clinical insertion 
loss, bleeding in probing or the loss of alveolar bone 
by means of a radiological study. However, there is no 
consensus as to which is the best method to use. These 
parameters are used, not only to diagnose the disease 
but also to assess both its progression following the 
treatment phases and the need for more complex and 
invasive treatments (3).
However, in medical practice it is easy to evaluate the 
presence of chronic inflammatory periodontal disease 
by means of a panoramic radiography (OPG). This pro-
cedure involves measuring the alveolar bone loss in the 
tooth which has the greatest loss out of all of those pres-
ent. The instruction given to doctors for this method is 
simple and very useful as all patients who present with 
more than 1/3 of alveolar loss are classified as having 
chronic inflammatory disease (4).
There is considerable evidence regarding the associa-
tion between PD and systemic diseases such as renal 
dysfunction, diabetes mellitus, rheumatoid arthritis, 
Alzheimer’s disease, cardiovascular risk, obesity, or 
cerebrovascular disease (5,6). The relationship between 
PD and these systemic diseases is bidirectional mean-
ing therefore that PD can cause adverse results and that 
certain systemic diseases can predispose a person to 
have periodontitis (3). This relationship is explained 
by the elevation of pro-inflammatory markers in the 
bloodstream that are observed in periodontal infection, 
which will decrease following periodontal therapy, and 
which can result, for example, in insulin resistance (7). 
Likewise, the bacterial colonisation of PD-causing bac-
teria such as P.gingivalis, T. forsythia and A. actinomy-
cetecomitans, were found in atheromatous plaques (3). 
Another association which has undergone considerable 
study is the relationship between PD and the delivery of 
a preterm infant (8).
However, despite the prevalence of PD, there is still 
not enough awareness amongst the majority of general 
practitioners worldwide who are not specialised in the 
oral cavity with regards to its relationship with systemic 
diseases and the need to treat affected patients (9,10). 
It is therefore necessary for doctors and other health 
professionals to educate patients regarding this relation-
ship and to recommend them dental care and oral health 
restoration procedures given that the evidence suggests 
that the treatment of PD leads to an improvement in the 
systemic pathology (3).
The aim of our study is to evaluate whether or not the ra-
diological diagnosis of PD can aid the detection of blood 
alterations associated with acquired systemic diseases.
Material and Methods 
- Study design
It is a cross sectional study. The calculation of the sam-
ple size was estimated in relation to the patients treated 
in the Oral Health Service (the target population covers 
the probability of the disease). Thus, for a general popu-
lation of health coverage of 34000 inhabitants, with an 
annual health care of 2600 patients, with about 300 first 
consultations (study inclusion criteria), for a two-year 
study, assuming heterogeneity of 50%, margin error of 
5% and confidence level of 95%, the appropriate sample 
size would be 235 patients. This sample size has been 
calculated with Epidat 2.4 (SERGAS, Galicia, Spain).
The exposition of this study has been designed accord-
ing to the STROBE recommendations for observational 
studies. The data was collected from January 2017 to 
January 2019. All of the procedures were carried out 
with the proper understanding and written consent of 
the subjects in accordance with the Declaration of Hel-
sinki and its subsequent modifications.
- Study inclusion/exclusion criteria
Inclusion criteria: All patients, over the age of 18 who 
attended a primary dental care service in Santiago de 
Compostela, Spain and who had not previously been 
diagnosed with PD were included systematically. All 
of the patients who decided to participate in the study 
signed an informed consent form and they underwent a 
OPG and a complete blood analysis.
Exclusion criteria: Patients under the age of 18, pregnant 
patients, those who had previously been treated peri-
odontally, and those who refused to sign the informed 
consent form were excluded.
- Radiographic study
OPGs were performed using an orthopantomographer 
with radiographic values of 65Kv and 6mA. The images 
were saved and managed with the Sidexis® Software 
(Dentsply Sirona Inc., Pennsylvania, USA). The OPG 
allowed for the evaluation of the number of teeth pres-
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one hour), Prothrombin Time, INR, Fibrinogen, Glu-
cose, Urea, Uric Acid, Creatinine, Sodium, Potassium, 
Bilirubin, AST / GOT, ALT / GPT, GGT, Alkaline 
Phosphatase, Total Proteins, Albumin, Calcium, Cho-
lesterol, Triglycerides, HDL, LDL, Thyrotropin (TSH), 
Glycosylated Haemoglobin A1c (HBA1c).
- Statistical analysis
Descriptive statistics were performed using frequencies 
and percentages for categorical variables, and means 
and standard deviations were taken for quantitative 
variables. The normality of the variables was verified 
by the Kolmogorov-Smirnov test. The contingency ta-
bles were constructed using the chi-square test. The sta-
tistical analysis was performed by comparing the vari-
ables using the ANOVA or U-Mann-Whitney tests for 
independent samples with normal conditions. The cor-
relation coefficient was analysed using the Pearson test. 
Correlation analysis were performed to verify that the 
analytical and analytical results make sense biomedical 
and clinical. All of the differences in which the value of 
p was less than or equal to 0.05 were considered to be 
statistically significant.
Results
A total of 239 patients were included in this study.  The 
final sample consisted of 96 men and 143 women with 
an average age of 64.40 years (SD = 12.66) and an age 
range of between 40 and 91 years old. We observed that 
59.04% of the patients had MBL. The descriptive data 
and the analysis of the relationship of the variables of 
the study with bone loss can be seen in Table 1.
ent as well as the overall alveolar bone loss. An anatom-
ical morphological criterion was followed in which it 
is considered that there is positive morphological bone 
loss (MBL) when there is more than 1 tooth with loss 
greater than or equal to the middle third of the radicle, 
as previously recommended by other authors (4).
- Evaluation of cases
Two specialised dentists (MPS and CCP) and a primary 
care physician (JSQ) were trained to analyse the radio-
graphs. Two evaluators evaluated, in a pilot study of 20 
radiographs, the existence of morphological bone loss, 
the agreement between the two independent evaluators, 
was 100%.
- Data and variables
The patients’ data was collected from their clinical re-
cords in a database specifically designed for that pur-
pose.  The data was analysed anonymously by assign-
ing a code to each patient so that the data could not be 
associated with a specific patient. Two independent 
researchers input the patient data, in duplicate, in or-
der to eliminate any potential errors. The clinical and 
radiological variables collected for each patient were: 
age, gender, systemic diseases, presence or absence of 
MBL, and number of missing teeth (without taking into 
account third molars).
- Blood study
With regards to the blood study, the levels of the fol-
lowing elements were considered: Leukocytes, Red 
Blood Cells, Haemoglobin, Haematocrit, Platelets, 
Neutrophils, Lymphocytes, Monocytes, Eosinophils, 
Basophils, ESR (Erythrocyte Sedimentation Rate after 
Table 1: Descriptive data and relationship analysis of study’s variables with bone loss.




MBL absence 92 63,03 14,12 60,11 65,96 ,187
MBL presence 147 65,26 11,63 63,36 67,15  
Total 239 64,40 12,66 62,79 66,02  
Number of missing 
teeth
MBL absence 92 21,65 7,37 20,12 23,18 ,000
MBL presence 147 17,32 7,64 16,07 18,56  
Total 239 18,99 7,81 17,99 19,98  
Leukocytes
MBL absence 92 7,00 1,94 6,60 7,40 ,228
MBL presence 147 7,34 2,24 6,98 7,71  
Total 239 7,21 2,13 6,94 7,48  
Red Blood Cells
MBL absence 92 4,58 0,44 4,49 4,67 ,325
MBL presence 147 4,64 0,50 4,56 4,72  
Total 239 4,62 0,48 4,56 4,68  
Haemoglobin
MBL absence 92 13,83 1,35 13,54 14,11 ,162
MBL presence 147 14,09 1,49 13,85 14,34  
Total 239 13,99 1,44 13,81 14,17  
Haematocrit
MBL absence 92 41,27 3,66 40,51 42,02 ,302
MBL presence 147 41,81 4,15 41,13 42,49  
Total 239 41,60 3,97 41,10 42,11  
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Platelets
MBL absence 92 242,14 68,13 228,03 256,25 ,024
MBL presence 147 223,02 60,08 213,23 232,81  
Total 239 230,38 63,84 222,25 238,52  
Neutrophils
MBL absence 92 4,08 1,62 3,74 4,41 ,727
MBL presence 147 4,16 1,92 3,85 4,48  
Total 239 4,13 1,81 3,90 4,36  
Lymphocytes
MBL absence 92 2,10 0,64 1,97 2,23 ,339
MBL presence 147 2,20 0,89 2,06 2,35  
Total 239 2,16 0,80 2,06 2,27  
Monocytes
MBL absence 92 0,46 0,16 0,43 0,49 ,715
MBL presence 147 0,47 0,16 0,44 0,49  
Total 239 0,46 0,16 0,44 0,48  
Eosinophils
MBL absence 92 0,21 0,14 0,18 0,24 ,701
MBL presence 147 0,22 0,16 0,19 0,24  
Total 239 0,21 0,15 0,19 0,23  
Basophils
MBL absence 92 0,04 0,03 0,04 0,05 ,415
MBL presence 147 0,04 0,03 0,04 0,05  




MBL absence 92 5,43 8,88 3,60 7,27 ,182
MBL presence 147 7,45 12,61 5,39 9,50  
Total 239 6,67 11,34 5,23 8,12  
Prothrombin Time
MBL absence 27 11,94 3,31 10,64 13,25 ,192
MBL presence 39 11,02 2,38 10,25 11,79  
Total 66 11,40 2,81 10,71 12,09  
INR
MBL absence 26 1,08 0,30 0,96 1,20 ,191
MBL presence 45 1,01 0,14 0,97 1,06  
Total 71 1,04 0,21 0,99 1,09  
Fibrinogen
MBL absence 20 389,55 59,26 361,81 417,29 ,569
MBL presence 29 371,38 132,41 321,01 421,74  
Total 49 378,80 108,16 347,73 409,86  
Glucose
MBL absence 88 98,73 27,33 92,94 104,52 ,378
MBL presence 142 102,19 29,86 97,24 107,14  
Total 230 100,87 28,91 97,11 104,62  
Urea
MBL absence 73 44,53 17,72 40,40 48,67 ,573
MBL presence 120 43,27 13,33 40,86 45,68  
Total 193 43,75 15,11 41,60 45,89  
Uric acid
MBL absence 76 5,18 1,69 4,79 5,56 ,545
MBL presence 115 5,32 1,46 5,05 5,59  
Total 191 5,26 1,55 5,04 5,48  
Creatinine
MBL absence 88 0,85 0,40 0,76 0,94 ,455
MBL presence 142 1,82 12,19 -0,20 3,85  
Total 230 1,45 9,58 0,21 2,70  
Sodium
MBL absence 75 140,32 2,32 139,79 140,85 ,402
MBL presence 122 140,61 2,44 140,18 141,05  
Total 197 140,50 2,39 140,17 140,84  
Potassium
MBL absence 75 4,48 0,42 4,38 4,58 ,718
MBL presence 119 4,50 0,42 4,43 4,58  
Total 194 4,49 0,42 4,43 4,55  
Bilirubin
MBL absence 51 0,60 0,27 0,52 0,67 ,363
MBL presence 87 0,56 0,23 0,51 0,61  
Total 138 0,57 0,25 0,53 0,61  
AST/GOT
MBL absence 65 26,15 25,48 19,84 32,47 ,203
MBL presence 102 22,67 8,41 21,01 24,32  
Total 167 24,02 17,22 21,39 26,65  
Table 1 cont.: Descriptive data and relationship analysis of study’s variables with bone loss.
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ALT/GPT
MBL absence 70 28,13 29,24 21,16 35,10 ,133
MBL presence 116 23,42 12,90 21,05 25,79  
Total 186 25,19 20,68 22,20 28,18  
GGT
MBL absence 66 32,89 35,49 24,17 41,62 ,825
MBL presence 102 31,64 36,06 24,55 38,72  
Total 168 32,13 35,74 26,69 37,57  
Alkaline Phosphatase
MBL absence 55 149,75 46,93 137,06 162,43 ,058
MBL presence 90 167,94 60,25 155,33 180,56  
Total 145 161,04 56,11 151,83 170,25  
Total Proteins
MBL absence 42 6,94 0,40 6,81 7,06 ,818
MBL presence 62 6,96 0,49 6,83 7,08  
Total 104 6,95 0,45 6,86 7,04  
Albumin
MBL absence 46 4,19 0,75 3,97 4,42 ,522
MBL presence 72 4,26 0,37 4,17 4,35  
Total 118 4,24 0,55 4,14 4,33  
Calcium
MBL absence 44 9,31 0,35 9,20 9,42 ,714
MBL presence 73 9,34 0,45 9,23 9,44  
Total 117 9,33 0,42 9,25 9,40  
Cholesterol
MBL absence 76 198,83 39,33 189,84 207,82 ,894
MBL presence 115 198,06 38,64 190,92 205,20  
Total 191 198,37 38,81 192,83 203,91  
Triglycerides
MBL absence 73 121,52 61,35 107,21 135,84 ,514
MBL presence 110 129,15 86,11 112,87 145,42  
Total 183 126,10 77,10 114,86 137,35  
HDL
MBL absence 62 53,44 15,82 49,42 57,45 ,340
MBL presence 84 57,31 28,83 51,05 63,56  
Total 146 55,66 24,18 51,71 59,62  
LDL
MBL absence 62 120,27 33,39 111,80 128,75 ,719
MBL presence 85 122,39 36,32 114,55 130,22  
Total 147 121,50 35,01 115,79 127,20  
Thyrotropin (TSH)
MBL absence 52 3,31 4,09 2,17 4,45 ,846
MBL presence 74 3,58 9,45 1,39 5,77  
Total 126 3,47 7,68 2,11 4,82  
Glycosylated Haemog-
lobin A1c (HBA1c)
MBL absence 32 5,73 1,08 5,35 6,12 ,009
MBL presence 46 6,24 1,40 5,83 6,66  
Total 78 6,03 1,29 5,74 6,33  
Patients with positive MBL had an average of 4 teeth 
less (17.32 teeth (SD = 7.64)) than patients with negative 
MBL (21.65 teeth (SD = 7.37)) (p <0.0001). In a bivariate 
analysis we found statistically significant results which 
demonstrated that patients who presented a visible 
MBL on the OPG had lower mean platelet levels 223.02 
u / microl (SD = 60.08) compared to 242.14 u / microl 
(SD = 68.13) (p = 0.024). Likewise, patients suffering 
from MBL had higher mean levels of HBA1c, 6.24 IU / 
ml (SD = 1.40) compared to 5.73 (SD = 1.08) (p = 0.009). 
The mean age of patients with MBL was 2 years greater, 
65.26 years (SD = 11.63) compared to 63.03 years (SD 
= 14.12) but there were no statistically significant dif-
ferences. We found that the alkaline phosphatase levels 
were higher in patients with MBL, 167.94 IU / l (SD = 
60.25) compared to 149.75 IU / l (SD = 46.93) but there 
were no statistically significant differences (p = 0.058). 
We did not find any other relationship between MBL 
and blood parameters or clinical variables.
The correlation study reveals that there are numerous 
statistically significant correlations (Table 2), although 
we can highlight those in which the correlation coef-
ficient (CC) is above 0.4 (moderate positive correlation). 
Therefore, age and teeth correlated inversely (CC = 
-0.434; p <0.001), age and urea correlated directly (CC 
= 0.464; p<0.001), HbA1c and glucose correlated posi-
tively (CC = 0.845, p<0. 001) and HbA1c and sodium 
correlated inversely (CC = -0.492; p<0.001).
Table 1 cont.: Descriptive data and relationship analysis of study’s variables with bone loss.
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 Age Missing Teeth Lc Hb Hmt Nf Lf Mc Bf VSG TPT
Age
CC 1 -,434** -,168** -,140* -,108 -,113 -,201** -,080 -,212** ,165* ,181
p value  ,000 ,009 ,030 ,097 ,082 ,002 ,218 ,001 ,011 ,145
N 239 239 239 239 239 239 239 239 239 239 66
Missing 
Teeth
CC -,434** 1 ,001 ,140* ,129* -,007 ,063 -,023 ,105 -,091 -,049
p value ,000  ,987 ,030 ,046 ,910 ,332 ,718 ,106 ,159 ,696
N 239 239 239 239 239 239 239 239 239 239 66
Platele
CC -,217** ,085 ,260** -,076 -,019 ,177** ,330** ,243** ,267** ,131* -,272*
p value ,001 ,190 ,000 ,242 ,767 ,006 ,000 ,000 ,000 ,044 ,027
N 239 239 239 239 239 239 239 239 239 239 66
HbA1c
CC ,136 -,275* ,271* -,186 -,121 ,145 ,360** ,112 ,055 ,257* -,142
p value ,235 ,015 ,016 ,102 ,291 ,205 ,001 ,329 ,630 ,023 ,627
N 78 78 78 78 78 78 78 78 78 78 14
 INR Fbg Gc Urea AU Na Brb Alb CT TSH HbA1c
Age
CC ,219 -,017 ,154* ,464** ,230** ,065 ,092 ,002 -,165* ,080 ,136
p value ,066 ,910 ,019 ,000 ,001 ,367 ,283 ,981 ,023 ,376 ,235
N 71 49 230 193 191 197 138 118 191 126 78
Missing 
Teeth
CC -,127 ,167 -,187** -,112 -,029 -,045 -,004 ,035 ,036 -,199* -,275*
p value ,290 ,252 ,004 ,122 ,692 ,529 ,966 ,708 ,619 ,026 ,015
N 71 49 230 193 191 197 138 118 191 126 78
Platele
CC -,237* -,041 ,030 -,305** -,218** -,111 -,236** -,249** ,184* -,067 ,120
p value ,047 ,779 ,648 ,000 ,002 ,121 ,005 ,007 ,011 ,458 ,296
N 71 49 230 193 191 197 138 118 191 126 78
HbA1c
CC -,143 -,124 ,845** ,057 -,131 -,492** -,240 -,064 -,130 -,023 1
p value ,626 ,700 ,000 ,660 ,256 ,000 ,083 ,663 ,260 ,855  -
N 14 12 78 63 77 71 53 49 77 68 78
Lc (Leukocytes); Hb (Haemoglobin); Hmt (Haematocrit); Nf (Neutrophils); Lf (Lymphocytes); Mc (Monocytes); Bf (Basophils); VSG (Eryth-
rocyte Sedimentation Rate after one hour); TPT (Prothrombin Time); Fbg (Fibrinogen); Gc (Glucose); AU (Uric Acid); Na (sodium); Brb 
(bilirubin); Alb (albumin); Ca (calcium); CT (cholesterol); TSH (Thyrotropin); HbA1c (Glycosylated Haemoglobin A1c). *p<0,05; **p<0,01.
Table 2: Correlation study of the mean variables.
Discussion
A total of 239 patients were included in this study, and 
more than half, 59.04%, presented with MBL. This 
prevalence is considerably greater than the results re-
corded in other studies within same geographic terri-
tory where a prevalence of 30% is estimated (11).
The different morphometric indices which are measur-
able in OPG have been studied for the identification 
of PD (12,13) and other diseases such as osteoporosis, 
sickle cell disease or macular degeneration (14,15). This 
can be explained by the fact that many systemic pathol-
ogies share risk factors (as smoking, diet, etc.) with PD, 
and may have similar etiologic mechanisms.
The statistical analyses of our study reveal an associa-
tion between the MBL and the number of teeth, as well 
as the age and the number of teeth. Taking into account 
that the final consequence of PD is the loss of teeth, it 
seems evident that over time the number of teeth of pa-
tients diagnosed with periodontitis will decrease.
Another significant finding from our analysis was the 
association of lower levels of platelets in patients with 
MBL. The main function of platelets is haemostasis, 
but these also promote chronic inflammatory reactions, 
such as atherosclerosis, modulate acute inflammatory 
processes (16) such as infections, and contribute to the 
exacerbation of autoimmune conditions such as asthma 
or arthritis (17). There is a clear relationship between 
changes in the platelet count and its function with age. 
Although the platelet response increases with age, the 
count decreases in patients aged over 60 (18). This co-
incides with our findings given that the mean age of our 
patients was 64.40 years, from an age range of 40-91 
years, and statistical analyses showed an inverse cor-
relation between platelet count and age.
A positive correlation of platelets and leukocytes has 
also been observed in this study. Maybe, this result is 
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determined by the fact that platelets, through the ex-
pression of toll-like receptors, mediate the inflammato-
ry response by interacting with leukocytes. Although a 
cause effect relationship cannot be warranted, previous 
studies have also observed this association in patients 
with PD (19).
Caula et al. discovered an association between increased 
alkaline phosphatase and blood creatinine and PD (20). 
We did not find differences in creatinine concentra-
tion between patients with positive MBL and negative 
MBL. We did find differences in the concentration of 
alkaline phosphatase, although this was not statistically 
significant (p = 0.058). Perhaps this is due to the fact 
that through the MBL criterion we have not assessed 
the severity of PD, a condition that Caula et al. took 
into account when studying the relationship. De et al. 
analysed alkaline phosphatase in patients with chronic 
PD, with and without type 2 diabetes mellitus, finding a 
significantly higher concentration in the first group (21). 
Jeyasree et al. also found a decrease in alkaline phos-
phatase in blood following the first phase of periodontal 
treatment in patients with chronic periodontitis (22).
Positive MBL patients have presented significantly 
higher average HbA1C levels. The prevalence of patients 
with PD is significantly higher in individuals with dia-
betes or with a precondition to suffer from diabetes (23). 
The coagulation cascade dysfunction has been widely 
studied in diabetic patients. In type 2 diabetes platelets 
adhere to the vascular endothelium and aggregate more 
rapidly than in healthy individuals (24,25). Coinciding 
with our previous results, platelets would initiate a vas-
cular adhesion process and the amount of circulating 
platelets would decrease. Many randomised studies have 
attempted to associate the deregulation of HbA1C, either 
as a diagnostic marker between healthy patients and pa-
tients with PD, or with the same patients before and af-
ter periodontal treatment (26). Numerous studies asso-
ciate the presence of PD with an increased risk of type 
2 diabetes, and longitudinal studies reveal a reduction 
in HbA1C of 0.27-0.48% following periodontal therapy 
after 3 months of follow-up (26). However, although all 
studies show some effect, not all of the results are sta-
tistically significant (3,27,28), and we cannot forget that 
many systemic diseases share etiological mechanisms 
that have not been studied in depth in these analysis.
Our findings coincide with the study by Montero et al. 
(29) who developed a predictive model for severe and 
moderate periodontitis in Americans between 2011 and 
2012. More than 3000 patients were included in this 
study, and age, gender, ethnicity, smoking habits and 
HbA1C were identified as variables for the predictive 
model of the disease, reaching a sensitivity of 70% and 
a specificity of 67.6 %.
Given its asymptomatic character, except in advanced 
stages, the identification of PD is sometimes conflict-
ing, but taking into account the prevalence of the dis-
ease it seems clear that there is an infra diagnosis of 
this disorder. The use of the MBL is simple, it does not 
require additional instruments (specific periodontal 
instruments, periodontal tests for bleeding and bacte-
rial plaque, etc.), and it is easily applied by the health 
professional. The MBL can be an additional tool when 
the OPG is taken for medical diagnosis and to evaluate 
paradental bone margin. The objective of using OPG by 
general practitioners, does not seek the diagnosis and 
accurate classification of the PD suffered by the patient, 
but a general screening to be able to subsequently re-
fer to the dentist or periodontal specialist. Parameters 
such as retraction, depth of probing, loss of insertion 
and periodontal probing technique are essential for the 
specific diagnosis of PD, and require deeper and more 
complex knowledge than the generic use of OPG.
Due to the preventable and treatable nature of peri-
odontitis, subjects diagnosed with periodontitis should 
be informed and treated so that the bacterial load and 
the hyperproduction of pro-inflammatory cytokines 
can be reduced, thus promoting a better quality of life, 
especially in patients with advanced age (30). Cases of 
dementia have expanded among the elderly population. 
The number of patients with dementia is expected to 
triple by 2050, and most cases of dementia are associ-
ated with Alzheimer’s disease. Through this approach 
there is a special interest in identifying modulate risk 
factors (such as PD) for dementia and Alzheimer’s dis-
ease since it is estimated that these factors can contrib-
ute to 30-50% of cases (30).
Limitations in our study include the lack of classifica-
tion between the types of PD, and the lack of analysis 
on the active state of PD, which, as we have seen, could 
influence the alteration of markers. Other limitation of 
our study is that OPG is not useful to detect PD activity, 
since it shows more historical aspects associated with 
destruction. Radiographic alterations produced by PD 
implies a late diagnosis. In this study bone loss associ-
ated with endodontic pathology, possible dental fissure 
or occlusal trauma has not been taken into account. It is 
important to remark that this is a cross-sectional study 
and relationships between variables cannot assure a 
cause-effect relation.
In view of the foregoing, the incorporation of the MBL 
parameter into our dental care and primary medical 
care protocol may be useful both for dentists and pri-
mary care physicians.
The statistical analysis revealed association between 
the MBL and variables as lower levels of platelets, high-
er average HbA1C levels, the number of teeth, and also 
the age and the number of teeth. This work provides 
data that allows establishing a line of work that attempts 
to correlate diagnosed PD with blood disorders due to 
systemic diseases.
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